{'fraction_non_alphanumeric': 0.03837471783295711, 'fraction_numerical': 0.03160270880361174, 'mean_word_length': 5.335714285714285, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Evidence-based Psychopharmacology: Introduction to the Series

The pioneers of modern psychopharmacology prided themselves on the empirical nature of their work, and the rigor of their clinical data. Evidence-based medicine emphasizes the importance of searching for relevant studies and making decisions in the light of the data (Sackett et al., 1996), and therefore has immediate appeal for our field. Of course, clinical decisions are only as good as the existing evidence, and critics have rightly pointed out the necessity for good clinical judgement and for further research when the data is poor (Klein, 1993; Rush, 2001; Wells, 1999). Nevertheless, there has been a steady growth in methods for systematically reviewing the literature, assessing the clinical trials database, and optimizing clinical decision-making (Chalmers and Altman, 1995; Eddy, 1996; Fawcett et al., 1999).